|
REVBW Revelation Biosciences 1810560 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-3,009,051.00 |
| Balance Sheet |
|
Current Assets
|
$14,206,035.00 |
|
Assets
|
$15,044,282.00 |
|
Current Liabilities
|
$1,417,146.00 |
|
Liabilities
|
$2,055,329.00 |
|
Equity
|
$12,988,953.00 |
|
Shares Out
|
3908420.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,214,851.00 |
|
Investing Cash Flow
|
$-71,879.00 |
| Market Analysis |
Market Cap
|
$39,084.20 |
|
Price
|
$0.01 |
|
BVPS
|
3.32 |
|
EPS
|
-2.71 |
|
FCF
|
$-3,286,730.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:56 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:02:00 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view REVBW documents filed with the SEC.
REVBW Filings
Clear
